Publications and Presentations Database
APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts..
PLoS medicine. 14(3), e1002254. Abstract
(2017).
Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study..
Cancer causes & control : CCC. 28(3), 191-201. Abstract
(2017).
Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease: A Randomized Trial..
Annals of internal medicine. 164(3), 155-63. Abstract
(2016).
Consumer Perceptions of Interactions With Primary Care Providers After Direct-to-Consumer Personal Genomic Testing..
Annals of internal medicine. 164(8), 513-22. Abstract
(2016).
Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment..
Journal of Alzheimer's disease : JAD. 52(1), 17-24. Abstract
(2016).
Tactical, strategic, and life-goal self-regulation of driving by older adults: development and testing of a questionnaire.
Journal of safety research. 46, 107-17. Abstract
(2013).
On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing?.
Medical decision making. 33(1), 71-7. Abstract
(2013).
Associations between risk perceptions and worry about common diseases: a between- and within-subjects examination.
Psychology & Health. 28(4), 434-49. Abstract
(2013).
Navigating a research partnership between academia and industry to assess the impact of personalized genetic testing.
Genetics in medicine : official journal of the American College of Medical Genetics. 14(2), 268-73. Abstract
(2012).
Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease.
Genetics in medicine : official journal of the American College of Medical Genetics. 14(8), 742-8. Abstract
(2012).
Preferences among diseases on a genetic susceptibility test for common health conditions: an ancillary study of the multiplex initiative.
Public health genomics. 15(6), 322-6.
(2012).
Personalized oncology through integrative high-throughput sequencing: a pilot study.
Science translational medicine. 3(111), 111ra121. Abstract
(2011).
Willingness to pay for genetic testing for Alzheimer's disease: a measure of personal utility.
Genetic testing and molecular biomarkers. 15(12), 871-5. Abstract
(2011).
Direct-to-consumer genetic testing: an assessment of genetic counselors' knowledge and beliefs.
Genetics in medicine : official journal of the American College of Medical Genetics. 13(4), 325-32. Abstract
(2011).
Returning individual research results: development of a cancer genetics education and risk communication protocol.
Journal of empirical research on human research ethics : JERHRE. 5(3), 17-30. Abstract
(2010).
Effect of Alzheimer disease genetic risk disclosure on dietary supplement use.
The American journal of clinical nutrition. 91(5), 1402-7. Abstract
(2010).
Successful aging in the United States: prevalence estimates from a national sample of older adults..
The journals of gerontology. Series B, Psychological sciences and social sciences. 65B(2), 216-26. Abstract
(2010).
Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members.
Neurology. 75(5), 425-31. Abstract
(2010).
"I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.
Genetics in medicine : official journal of the American College of Medical Genetics. 12(4), 219-27. Abstract
Download: PDF (310.84 KB)
(2010).
Black and white adult family members' attitudes toward a dementia diagnosis.
Journal of the American geriatrics society. 57(9), 1562-8. Abstract
(2009).
Living at risk: the sibling's perspective of early-onset Alzheimer's disease.
Journal of genetic counseling. 18(3), 239-51. Abstract
(2009).
Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine. 361(3), 245-54. Abstract
(2009).
Disclosure of APOE genotype for risk of Alzheimer's disease.
The New England journal of medicine. 361(3), 245-54. Abstract
(2009).
A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.
Alzheimer disease and associated disorders. 23(1), 50-6. Abstract
(2009).